Sreepathi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.20 Cr
as on 09-07-2024
- Paid Up Capital ₹ 3.70 Cr
as on 09-07-2024
- Company Age 40 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 70.24 Cr
as on 09-07-2024
- Satisfied Charges ₹ 46.68 Cr
as on 09-07-2024
- Revenue 22.37%
(FY 2022)
- Profit -86.79%
(FY 2022)
- Ebitda 11.80%
(FY 2022)
- Net Worth 0.23%
(FY 2022)
- Total Assets 6.63%
(FY 2022)
About Sreepathi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.20 Cr and a paid-up capital of Rs 3.70 Cr.
The company currently has active open charges totaling ₹70.24 Cr. The company has closed loans amounting to ₹46.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivas Isola, Shyamala Isola, Satya Akhil, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG1983PLC004356
- Company No.
004356
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Dec 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sreepathi Pharmaceuticals Limited offer?
Sreepathi Pharmaceuticals Limited offers a wide range of products and services, including Chemical Compound, API (Active Pharmaceutical Ingredients), Pharma Ingredients & Raw Materials, Anti Infective API, Veterinary Medicines, Enrofloxacin Injections, Antibiotic Tablets & Capsules, Ciprofloxacin Tablets.
Who are the key members and board of directors at Sreepathi Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Isola  | Managing Director | 09-Mar-2006 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karthik Chandra | Director | 04-Jul-2018 | Current |
| Shyamala Isola | Whole-Time Director | 08-Apr-2006 | Current |
| Satya Akhil | Director | 27-Aug-2009 | Current |
Financial Performance and Corporate Structure Insights of Sreepathi Pharmaceuticals.
Sreepathi Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.37% increase. The company also saw a substantial fall in profitability, with a 86.79% decrease in profit. The company's net worth moved up by a moderate rise of 0.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sreepathi Pharmaceuticals?
In 2022, Sreepathi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Whitestar Business Consulting LlpActive 2 years 10 monthsSrinivas Isola, Shyamala Isola and 1 more are mutual person
- Sreemrr Eco Green Industries Private LimitedActive 14 years 4 months
Srinivas Isola is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 28 Sep 2018 | ₹29.75 Cr | Open |
Hdfc Bank Limited Creation Date: 03 Nov 2015 | ₹40.49 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 19 Nov 2015 | ₹1.20 Cr | Satisfied |
How Many Employees Work at Sreepathi Pharmaceuticals?
Sreepathi Pharmaceuticals has a workforce of 108 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sreepathi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreepathi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
